Skip to content

A study on the reduction of opioid dosage during supporting laryngoscope surgery by thyroid cartilage plane block

A study on the reduction of opioid dosage during supporting laryngoscope surgery by thyroid cartilage plane block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102177
Enrollment
Unknown
Registered
2025-05-09
Start date
2024-05-21
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vocal cord polyps, vocal cord leukoplakia

Interventions

Control group (group C:Ordinary general anesthesia group)(Part I of the study):Patients who met the inclusion criteria were selected and only prepared for routine general anesthesia before surgery, an
experimental group (group S:Thyroid cartilage plane block group)(Part I of the study):Patients who met the inclusion criteria were selected to undergo nerve block before surgery, and then the ED95 of
Control group (group C:Ordinary general anesthesia group)(Part II of the study):Patients who met the inclusion criteria were selected, and only routine general anesthesia was prepared for surgery, and
experimental group (group S:Thyroid cartilage plane block group)(Part II of the study):Patients who met the inclusion criteria were selected to undergo nerve block before operation, and sufentanil ED9

Sponsors

Suzhou University Affiliated Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: Patients who are hospitalized for laryngoscopy with support 2: The preoperative general condition is OK, ASA grade I-II; Age 18-65 years; BMI index 18~28

Exclusion criteria

Exclusion criteria: 1: Has a history of neck surgery; 2: Long-term use of opioid analgesics, long-term use of drugs that affect the sympathetic-adrenergic system or hemodynamics; 3: Coagulation indicators are abnormal, and there are contraindications to nerve block; 4: Presence of a difficult airway.

Design outcomes

Primary

MeasureTime frame
Morphine equivalent (converted from sufentanil + total remifentanil);

Secondary

MeasureTime frame
Intraoperative use of ephedrine and atropine;Duration of surgery, time of extubation;MAP and HR by time period;Postoperative adverse reactions (such as dizziness, nausea and vomiting, skin itching, aspiration, dyspnea, etc.) in the two groups;Postoperative hoarseness, sore throat, and cough incidence and severity;

Countries

China

Contacts

Public ContactJiang Zhu

Suzhou University Affiliated Second Hospital

857496932@qq.com+86 139 6215 3438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026